|
|
| Model Number |
N/A |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
| Date of Event |
10/26/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been received by the manufacturer for evaluation.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.
|
| |
|
Event or Problem Description
|
|
It was reported tubing connected to the port needle was severed exposing patient to hd drug.No further information was provided.
|
| |
|
Event or Problem Description
|
|
Additional information provided 11/10.Medications infused (b)(6) 2025: cisplatin, etoposide, mesna, dexamethasone, ifosfamide, 5% dextrose, sodium chloride, magnesium sulfate, potassium phosphate, potassium chloride, famotidine, heparin lock (30 units), ondansetron.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Search Alerts/Recalls
|
|
|